Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Change in Intangibles (2024 - 2025)

Indivior Pharmaceuticals has reported Change in Intangibles over the past 2 years, most recently at $1.0 million for Q2 2025.

  • Quarterly results put Change in Intangibles at $1.0 million for Q2 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1.0 million (down 50.0% YoY), and the annual figure for FY2025 was $1.0 million, down 50.0%.
  • Change in Intangibles for Q2 2025 was $1.0 million at Indivior Pharmaceuticals, roughly flat from $1.0 million in the prior quarter.
  • Over the last five years, Change in Intangibles for INDV hit a ceiling of $1.0 million in Q1 2024 and a floor of $1.0 million in Q1 2024.